Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to CU20070249ApriorityCriticalpatent/CU23697B7/en
Publication of CU20070249A7publicationCriticalpatent/CU20070249A7/en
Publication of CU23697B7publicationCriticalpatent/CU23697B7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refuere a novedosos compuestos orgénicos de fórmula (I) ESPACIO PARA LA FÓRMULA a procesos para su preparación, a su aplicación en un proceso para el tratamiento del cuerpo humano o animal, a su uso- solo o en combinación con uno o más compuestos farmacéuticamente activos diferentes- para el tratamiento de una enfermedad inflamatoria u obstructiva de las vías respiratorias, tal como asma, trastornos que se presentan comúnmente en relación con transplante, o una enfermedad proliferativa, tal como una enfermedad tumoral.The invention relates to novel organic compounds of formula (I) SPACE FOR FORMULA to processes for their preparation, to their application in a process for the treatment of the human or animal body, to their use - alone or in combination with one or more Different pharmaceutically active compounds - for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders that commonly occur in relation to transplantation, or a proliferative disease, such as a tumor disease.
CU20070249A2007-11-082007-11-08
IMIDAZOQUINOLINAS AS INHIBITORS OF LIPID KINASES
CU23697B7
(en)
Compounds derived from heteroaryloxy amides of substituted benzoic acid, p38 map kinase inhibitors; compound preparation process; pharmaceutical composition; procedure for preparing said composition; and use in the treatment of airway diseases such as epoc and asthma.
Compounds derived from heterocycles, antagonists for ccr2; and use of the compounds to treat respiratory tract conditions or diseases, such as chronic obstructive pulmonary disease and asthma.
Compounds derived from phenylamino-isonicotinamide; mek inhibitors; Pharmaceutical composition and use for the treatment of hyperproliferative diseases such as cancer and inflammation.
Crystalline form a and b of 3- (2r-tetrahydrofuryl methyl) -2-thioxanthin; myeloperoxidase inhibitor; processes for its preparation; pharmaceutical formulation comprising them; and use in the treatment of neuroinflammatory disorders, cardio and cerebrovascular atherosclerotic disorders, heart failure, bronchitis.
DERIVATIVES OF (FENYL) -AMIDA OF THE ACID 7- (PIPERAZIN-1-ILMETIL) -1H-INDOL-2-CARBOXYLICAL AND RELATED COMPOUNDS IN QUALITY OF MAP-QUINASE INHIBITORS P38 FOR THE TREATMENT OF DISEASES OF THE RESPIRATORY ROADS